Online citations, reference lists, and bibliographies.
← Back to Search

Curcumin Nanotechnologies And Its Anticancer Activity

P. Subramani, K. Panati, V. R. Narala
Published 2017 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT Cancer is one of the leading causes of death worldwide. Curcumin is a well-established anticancer agent in vitro but its efficacy is yet to be proven in clinical trials. Poor bioavailability of curcumin is the principal reason behind the lack of efficiency of curcumin in clinical trials. Many studies prove that the bioavailability of curcumin can be improved by administering it through nanoparticle drug carriers. This review focuses on the efforts made in the field of nanotechnology to improve the bioavailability of curcumin. Nanotechnologies of curcumin come in various shapes and sizes. The simplest curcumin nanoparticle that increased the bioavailability of curcumin is the curcumin–metal complex. On the other hand, we have intricate thermoresponsive nanoparticles that can release curcumin upon stimulation (analogous to a remote control). Future research required for developing potent curcumin nanoparticles is also discussed.
This paper references
10.3109/10717544.2014.927021
In-situ implant containing PCL-curcumin nanoparticles developed using design of experiments
N. Kasinathan (2016)
10.1016/j.carbpol.2015.09.072
Composite chitosan hydrogels for extended release of hydrophobic drugs.
Keren Delmar (2016)
10.2217/nnm.13.35
ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells.
M. Ghosh (2014)
10.1016/j.nano.2010.08.002
Curcumin nanodisks: formulation and characterization.
M. Ghosh (2011)
10.2147/IJN.S36404
An optimized molecular inclusion complex of diferuloylmethane: enhanced physical properties and biological activity
Q. Tan (2012)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1007/978-1-60761-416-6_4
Mechanisms of multidrug resistance in cancer.
J. Gillet (2010)
10.3390/molecules191220091
The Chemistry of Curcumin: From Extraction to Therapeutic Agent
K. Priyadarsini (2014)
10.1016/j.archoralbio.2015.12.003
Comparative evaluation of PLGA nanoparticle delivery system for 5-fluorouracil and curcumin on squamous cell carcinoma.
Shaimaa M Masloub (2016)
10.1016/j.drudis.2014.09.018
Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Deepti Pandita (2015)
10.1016/j.nano.2011.07.011
Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
S. Dhule (2012)
10.1002/APP.33508
Synthesis and characterization of hydrogel‐silver nanoparticle‐curcumin composites for wound dressing and antibacterial application
K. Varaprasad (2011)
10.1007/s00280-013-2151-8
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
M. Kanai (2013)
10.1158/1535-7163.MCT-10-0172
Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer
S. Bisht (2010)
10.1139/bcb-2015-0009
Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas.
Natasha M. Crosby (2015)
An optimized molecular inclusion complex of diferuloylmethane: NUTRITION AND CANCER 391 enhanced physical properties and biological activity
Q Tan (2012)
10.1021/acs.molpharmaceut.5b00644
Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
Sugata Barui (2016)
10.1089/jamp.2010.0830
Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
Parthiban Selvam (2011)
10.1016/0300-483X(81)90027-5
Metabolism of curcumin--studies with [3H]curcumin.
V. Ravindranath (1981)
Theracurmin (R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest
M Kang (2015)
10.1248/BPB.34.660
Innovative preparation of curcumin for improved oral bioavailability.
H. Sasaki (2011)
10.1166/JBN.2009.1038
Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer.
D. Prajakta (2009)
10.1016/j.biomaterials.2014.06.040
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Murali M Yallapu (2014)
b-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells
MM Yallapu (2010)
10.1186/1477-3155-12-25
Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells
J. J. Pillai (2014)
10.1021/jp403724g
Modulation of the photophysical properties of curcumin in nonionic surfactant (Tween-20) forming micelles and niosomes: a comparative study of different microenvironments.
Sarthak Mandal (2013)
Differential distribution of intravenous curcumin formulations in the rat brain.
Simon S. Chiu (2011)
Preparation of curcuminoid niosomes for enhancement of skin permeation.
N. Rungphanichkul (2011)
10.1002/ijc.24336
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice
N. Narayanan (2009)
10.2147/IJN.S49882
Curcumin and 5-Fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia
S. Balasubramanian (2014)
10.1021/mp200351y
Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles.
I. ElSherbiny (2012)
10.1021/jf9024807
Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.
V. Gota (2010)
10.1016/j.bmcl.2015.12.060
Development of curcumin-cyclodextrin/cellulose nanocrystals complexes: New anticancer drug delivery systems.
Gautier M.A. Ndong Ntoutoume (2016)
10.1038/srep20051
Curcumin Nanoformulation for Cervical Cancer Treatment
M. Zaman (2016)
10.1016/j.nano.2011.06.011
A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells.
Yu-Ling Lin (2012)
10.1016/S0378-5173(98)00169-0
Non-ionic surfactant based vesicles (niosomes) in drug delivery
I. Uchegbu (1998)
10.2147/IJN.S27639
A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting
L. Zhang (2012)
10.1016/j.colsurfb.2013.09.058
Co-encapsulation of antioxidants into niosomal carriers: gastrointestinal release studies for nutraceutical applications.
L. Tavano (2014)
10.1007/s10856-014-5357-3
Enhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells
Benjamin Teong (2015)
10.1016/j.jcis.2010.05.022
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Murali M Yallapu (2010)
10.1016/J.BBAGEN.2006.06.012
Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study.
A. Kunwar (2006)
10.1016/j.jcis.2011.04.006
Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
N. S. Rejinold (2011)
10.1016/j.jcis.2011.11.024
Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
S. Man-ju (2012)
10.1158/1078-0432.CCR-07-5177
Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent Pathway
D. Wang (2008)
10.1016/j.colsurfb.2014.01.007
Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Lay Hong Chuah (2014)
10.4143/crt.2014.46.1.2
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
Sahdeo Prasad (2014)
10.1016/j.fct.2012.01.017
Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin.
Maqsood A. Siddiqui (2012)
10.1200/JCO.2015.61.6706
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.
L. Schnipper (2015)
10.1016/j.bcp.2009.09.003
Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.
P. Anand (2010)
10.1002/jps.24548
Orally Administered Chitosan-Coated Polycaprolactone Nanoparticles Containing Curcumin Attenuate Metastatic Melanoma in the Lungs.
G. Loch-Neckel (2015)
10.1016/j.critrevonc.2015.08.002
Anticancer treatment and fertility: Effect of therapeutic modalities on reproductive system and functions.
M. Vassilakopoulou (2016)
10.1177/1934578X1300800129
Challenges of Curcumin Bioavailability: Novel Aerosol Remedies
P. Subramani (2013)
10.1002/ANIE.200602866
Magnetic nanoparticles: synthesis, protection, functionalization, and application.
A. Lu (2007)
10.1371/journal.pone.0117526
Curcumin Conjugated with PLGA Potentiates Sustainability, Anti-Proliferative Activity and Apoptosis in Human Colon Carcinoma Cells
B. Waghela (2015)
10.1016/j.ejps.2015.11.010
Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin.
S. Kumar (2016)
10.1002/cncr.21300
Liposome‐encapsulated curcumin
L. Li (2005)
10.1248/BPB.B13-00150
Drinkable preparation of Theracurmin exhibits high absorption efficiency--a single-dose, double-blind, 4-way crossover study.
T. Morimoto (2013)
10.1016/j.surg.2011.12.014
Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition.
W. Orr (2012)
10.1007/s00280-011-1673-1
Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
M. Kanai (2011)
10.1016/j.canlet.2012.07.017
Multi-layer polymeric implants for sustained release of chemopreventives.
F. Aqil (2012)
10.2174/138920012798356952
Design of curcumin loaded cellulose nanoparticles for prostate cancer.
Murali M Yallapu (2012)
10.1016/j.nano.2014.02.004
Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells.
A. L. Palange (2014)
10.1021/jf9013923
Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin.
M. Takahashi (2009)
10.2147/IJN.S38043
Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin
C. Li (2012)
10.1016/j.ejpb.2015.06.002
Curcumin-Eudragit® E PO solid dispersion: A simple and potent method to solve the problems of curcumin.
J. Li (2015)
10.3322/caac.21262
Global cancer statistics, 2012
L. Torre (2015)
10.1186/1477-3155-8-28
Nanobiotechnology applications of reconstituted high density lipoprotein
R. Ryan (2010)
Authorising the Placing on the Market of Alpha-Cyclodextrin as a Novel Food Ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
A Vassiliou (2008)
10.1016/J.IJPHARM.2007.02.033
All-trans-retinoic acid nanodisks.
Katherine A Redmond (2007)
10.3322/caac.20107
Global cancer statistics
A. Jemal (2011)
10.1039/c0nr00758g
Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.
M. Gou (2011)
10.1208/s12249-013-0023-5
Molecular Inclusion Complex of Curcumin–β-Cyclodextrin Nanoparticle to Enhance Curcumin Skin Permeability from Hydrophilic Matrix Gel
H. Rachmawati (2013)
10.1016/j.bbagen.2014.01.016
Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells.
Sathish Sundar Dhilip Kumar (2014)
10.1016/j.bbcan.2012.05.004
Glioblastoma: therapeutic challenges, what lies ahead.
Flavia R.S. Lima (2012)
10.1002/CHIN.201536259
Metal Complexes of Curcumin — Synthetic Strategies, Structures and Medicinal Applications
Simon Wanninger (2015)
10.1016/j.ijpharm.2016.06.134
Fabrication of nanocomposite particles using a two-solution mixing-type spray nozzle for use in an inhaled curcumin formulation.
Moeko Taki (2016)
10.1038/164456A0
Antibacterial Action of Curcumin and Related Compounds
E. Schraufstätter (1949)
10.1158/1535-7163.MCT-12-1227
Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment
Murali M Yallapu (2013)
10.1016/j.biomaterials.2010.06.007
Curcumin polymers as anticancer conjugates.
Huadong Tang (2010)
10.3389/fonc.2013.00137
Nano-Curcumin Inhibits Proliferation of Esophageal Adenocarcinoma Cells and Enhances the T Cell Mediated Immune Response
F. Milano (2013)
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
M. McMenamin (1999)
10.3109/10428194.2011.584253
Curcumin nanodisk-induced apoptosis in mantle cell lymphoma
A. T. Singh (2011)
10.1016/j.bbagen.2014.06.004
Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
A. Anitha (2014)
10.1111/eci.12589
Update on cardiotoxicity of anti‐cancer treatments
Gian Marco Rosa (2016)
10.1016/j.biomaterials.2012.10.068
Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles.
C. Gong (2013)
10.1039/c5bm00479a
Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
Gopikrishna Moku (2016)
10.1016/j.colsurfb.2010.03.039
beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
Murali M Yallapu (2010)
10.1002/mnfr.201100741
Multitargeting by turmeric, the golden spice: From kitchen to clinic.
S. Gupta (2013)
Erratum: Non-ionic surfactant based vesicles (niosomes) in drug delivery (International Journal of Pharmaceutics 172 (1998) (33-70) PII: S0378517398001690)
I. Uchegbu (1998)
10.1208/s12249-009-9264-8
Effect of Cyclodextrin Complexation of Curcumin on its Solubility and Antiangiogenic and Anti-inflammatory Activity in Rat Colitis Model
Vivek R. Yadav (2009)
10.1016/j.ijpharm.2008.09.009
An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
C. Chen (2009)
10.1038/bjc.2012.379
Curcumin–cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer
N. Rocks (2012)
10.1186/s11671-015-1085-y
Evaluation of High-Performance Curcumin Nanocrystals for Pulmonary Drug Delivery Both In Vitro and In Vivo
L. Hu (2015)
10.1038/srep10881
A New Approach to Reduce Toxicities and to Improve Bioavailabilities of Platinum-Containing Anti-Cancer Nanodrugs
L. Liu (2015)
10.1166/JBN.2015.1925
Intracellular Uptake of Curcumin-Loaded Solid Lipid Nanoparticles Exhibit Anti-Inflammatory Activities Superior to Those of Curcumin Through the NF-κB Signaling Pathway.
J. Wang (2015)
10.1016/j.critrevonc.2015.03.003
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus.
A. Mirabile (2015)
10.1016/j.ejpb.2015.02.017
Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.
C. England (2015)
10.7314/APJCP.2013.14.9.5049
Cost of treatment for cancer: experiences of patients in public hospitals in India.
K. Nair (2013)
10.1016/j.ijpharm.2010.08.033
Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Jinghua Duan (2010)
Mohana Raju K: Synthesis and characterization of hydrogel-silver nanoparticlecurcumin composites for wound dressing and antibacterial application
K Varaprasad (2011)
10.1080/09205063.2014.917039
Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer: in vitro efficacy evaluation
R. Sridhar (2014)
10.1016/j.intimp.2011.11.015
Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo.
E. Babaei (2012)
10.4103/0975-7406.94825
Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer
M. Madhavi (2012)
10.1158/1940-6207.CAPR-10-0006
Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention
Shyam S. Bansal (2011)
10.1155/2016/6475624
Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies
A. Mileo (2016)
10.3892/or.2015.4537
Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
Minyong Kang (2016)
10.1263/JBB.100.1
Medical application of functionalized magnetic nanoparticles.
A. Ito (2005)
10.1002/adhm.201500750
Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy.
J. Fang (2016)
10.3978/j.issn.2218-6751.2015.08.04
Global trends of lung cancer mortality and smoking prevalence.
F. Islami (2015)
10.1517/17425247.2013.736962
Eudragit®: a technology evaluation
S. Thakral (2013)
Evaluation of highperformance curcumin nanocrystals for pulmonary drug delivery both in vitro and in vivo
L Hu (2015)
10.1016/j.ijpharm.2012.12.032
Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis.
L. Liu (2013)
Biotransformation of curcumin through reduction and glucuronidation in mice.
M. Pan (1999)
10.1016/j.semcancer.2014.06.004
A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
Monica Cojoc (2015)
10.1166/JBN.2016.2162
Synthesis and Characterization of Inhalable Flavonoid Nanoparticle for Lung Cancer Cell Targeting.
Wing-Hin Lee (2016)
10.1016/j.nano.2009.05.009
Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells.
R. Das (2010)
10.1038/nrd4333
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
V. Torchilin (2014)
Silica-coated flexible liposomes as a nanohybrid delivery system for 392 P. A. SUBRAMANI ET AL. enhanced oral bioavailability of curcumin
C Li (2012)
10.1016/j.bcp.2010.06.022
Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.
V. Yadav (2010)
10.1016/j.msec.2013.07.047
The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
P. Wang (2013)
10.1021/acsami.5b01786
Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
S. Patra (2015)
10.1194/jlr.D500033-JLR200
Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B Published, JLR Papers in Press, November 28, 2005.
M. Oda (2006)
10.1016/j.carbpol.2013.01.014
Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.
N. Zhou (2013)
10.1002/wnan.1384
Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development.
S. Swaminathan (2016)
10.5681/apb.2013.021
Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer.
F. Kazemi-Lomedasht (2013)
10.2147/IJN.S29290
Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications
Murali M Yallapu (2012)
10.3168/jds.2015-10391
Curcumin liposomes prepared with milk fat globule membrane phospholipids and soybean lecithin.
Hong-Hao Jin (2016)
Dualtargeting lactoferrin-conjugated polymerized magnetic polydiacetylene-assembled nanocarriers with self-responsive fluorescence/magnetic resonance imaging for in vivo brain tumor therapy
J H Fang (2016)
10.1016/J.BIOCEL.2007.04.026
The cellular origin of mantle cell lymphoma.
F. Bertoni (2007)
10.1016/j.fct.2010.05.008
Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies.
P. Dandekar (2010)
Dualtargeting lactoferrin-conjugated polymerized magnetic polydiacetylene-assembled nanocarriers with self-responsive fluorescence/magnetic resonance imaging for in vivo brain tumor
JH Fang (2016)
10.3233/JAD-140798
Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's disease.
Richard McClure (2015)
10.3389/fpls.2015.00799
Plant derived substances with anti-cancer activity: from folklore to practice
M. Fridlender (2015)
10.1016/J.APSB.2011.09.002
Nonionic surfactant vesicular systems for effective drug delivery—an overview
G. P. Kumar (2011)
10.3390/ijms16059236
In Vitro and in Vivo Antitumoral Effects of Combinations of Polyphenols, or Polyphenols and Anticancer Drugs: Perspectives on Cancer Treatment
Massimo Fantini (2015)
Theracurmin (R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.Oncol
M Kang (2015)
10.1158/1940-6207.CAPR-13-0248
Curcumin Implants, Not Curcumin Diet, Inhibit Estrogen-Induced Mammary Carcinogenesis in ACI Rats
Shyam S. Bansal (2014)
10.1016/j.biomaterials.2014.10.044
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
Liqiong Cai (2015)
A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma
孙海香 (2015)
10.1016/j.biomaterials.2010.11.028
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.
Murali M Yallapu (2011)



This paper is referenced by
10.1080/17425247.2020.1702644
A short review on chemical properties, stability and nano-technological advances for curcumin delivery
Layal Slika (2019)
10.3389/fphar.2020.00487
Nanocurcumin: A Promising Candidate for Therapeutic Applications
A. Karthikeyan (2020)
CHEMOPREVENTIVE EFFECTS OF PHENETHYL ISOTHIOCYANATE IN A GRAPHENE OXIDE BASED NANOCOMPOSITE AGAINST HUMAN LUNG, BREAST AND COLON CANCER CELL LINES
Dasan Mary Jaya Seema (2018)
10.1080/00914037.2019.1655751
Functional hydrophilic highly biodegradable PCL nanofibers through direct aminolysis of PAMAM dendrimer
Pouyan Razmshoar (2020)
10.1021/acsami.7b05469
Ultrasound-Responsive Polymeric Micelles for Sonoporation-Assisted Site-Specific Therapeutic Action.
Pengying Wu (2017)
curcumin on chemoresistance in doxorubicin-resistant breast cancerMcF-7/doX and Mda-MB-231/doX cell lines. cell counting Kit-8, monolayer transport, western blot and aTPase activity assays were performed during the study. The results revealed that curcumin significantly enhanced the effect of doxoru
Chunjie Wen (2019)
10.22038/ijbms.2019.35808.8530
The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7)
S. Hosseini (2019)
10.1016/j.ijpharm.2017.05.015
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates.
Ruozi Barbara (2017)
10.1016/J.TIFS.2018.11.026
A review on advanced microencapsulation technology to enhance bioavailability of phenolic compounds : Based on its activity in the treatment of Type 2 Diabetes
L. Chen (2019)
10.1007/978-3-030-39855-2_7
Adjuvant Value of Turmeric Extract (Containing Curcumin) in Colorectal Cancer Management
Clara Bik-San Lau (2020)
10.1155/2017/1634801
“mTOR Signaling Pathway”: A Potential Target of Curcumin in the Treatment of Spinal Cord Injury
Jingquan Lin (2017)
10.2147/DDDT.S175763
Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats
Qiaoding Dai (2018)
10.1002/ptr.6087
Phytotherapeutics in cancer invasion and metastasis
B. Salehi (2018)
10.1080/03639045.2020.1762202
Odorranalectin modified PEG–PLGA/PEG–PBLG curcumin-loaded nanoparticle for intranasal administration
Xinrui Li (2020)
10.1007/s40199-020-00331-2
HSA-curcumin nanoparticles: a promising substitution for Curcumin as a Cancer chemoprevention and therapy
Zahra Matloubi (2020)
10.1016/j.phymed.2018.07.001
Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis.
B. Salehi (2019)
10.1002/jcb.27775
Photodynamic treatment with anionic nanoclays containing curcumin on human triple‐negative breast cancer cells: Cellular and biochemical studies
Khatereh Khorsandi (2019)
10.1016/j.msec.2019.110550
Preparation of curcumin-poly (allyl amine) hydrochloride based nanocapsules: Piperine in nanocapsules accelerates encapsulation and release of curcumin and effectiveness against colon cancer cells.
Layal Slika (2020)
10.7150/ONCM.27938
Liposomes Aid Curcumin's Combat with Cancer in a Breast Tumor Model
Rahul Jadia (2018)
10.3390/jcm9030746
Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
B. Salehi (2020)
10.3892/mmr.2019.10180
Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells
Chunjie Wen (2019)
10.1002/jcb.26749
Curcumin on the “flying carpets” to modulate different signal transduction cascades in cancers: Next‐generation approach to bridge translational gaps
H. Çelik (2018)
Semantic Scholar Logo Some data provided by SemanticScholar